Presentations

Developing a Protected PCI Algorithm

Top Downloads
Abiomed Cardiogenic Shock Protocol

Abiomed Cardiogenic Shock Protocol

Data

Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device

Protected PCI

SEE ALL

Cardiogenic Shock

SEE ALL

Newsletter

SUBSCRIBE

Upcoming Events

10.04.18
Management of Patients in Cardiogenic Shock: Appropriate Use of Impella for Support and/or Transport
Cleveland, OH
Details
10.19.18
Introduction to Mechanical Circulatory Support: Impella Training for Fellows
Cleveland, OH
Details
11.11.18
Complex High Risk Intervention with Hemodynamic Support for Fellows -Mt. Sinai
New York, NY
Details
11.14.18
Management of Patients in Cardiogenic Shock: Appropriate Use of Impella for Support and/or Transport
Falls Church, VA
Details
12.07.18
ALL Access: Critical Skills for Advanced Interventional Operators
New York, NY
Details
Download Protocol
Meeting Summaries

2018 TCT: More Than 30 Sessions Showcasing Impella® Technology

September 10, 2018
Case Reviews

Complex PCI Involving Prior CABG and Comorbidities

Dr. Perwaiz Meraj of Northwell Health System joins Dr. George Vetrovec to discuss a complex coronary intervention of a 77 year ...
September 5, 2018
Cardiogenic Shock

Cardiogenic Shock Due to Severe Multi-Vessel Disease

Dr. Alexander Truesdell, Interventional Cardiologist from Inova Heart & Vascular Institute, presents a case of cardiogenic ...
August 28, 2018

Submit Your Case Review

Please fill in this form and a member of our medical team will contact you to arrange convenient time to record your case.
  • This field is for validation purposes and should be left unchanged.
#ProtectedPCI

ICYMI: Women With #CardiogenicShock Derive Greater Benefit From Early Mechanical Circulatory Support: An Update From the cVAD Registry bit.ly/2xDOxOv #TCT2018

From Protected PCI's Twitter

prev · next
#AbiomedImpella

Happening now in Presentation Theater Two! Dr. Michael Flaherty presenting on #Impella -assisted PCI and a strategy to prevent AKI in #highrisk patients #TCT2018 pic.twitter.com/0fEAiSzI0O

From Abiomed's Twitter

prev · next